Ocuphire Pharma appoints Nirav Jhaveri as CFO and Ash Jayagopal as Chief Scientific Officer

Opus Genetics, Inc.

Nirav Jhaveri appointed CFO effective Feb 12, 2024; base salary $410k, equity awards: 210k options + 140k RSUs.
Ash Jayagopal appointed Chief Scientific and Development Officer; 15+ years retinal disease experience, previously at Opus Genetics and Roche.
Jhaveri previously CFO at Insilico Medicine and Journey Medical; over 20 years biopharma finance experience.
Both appointments effective Feb 12, 2024, as company advances APX3330 phase 3 in diabetic retinopathy.
Jhaveri eligible for discretionary annual cash bonus up to 45% of base salary; severance includes 0.75x salary plus prorated bonus.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Nirav Jhaveri

Chief Financial Officer

IRD · Opus Genetics, Inc.

Effective: 2024-02-12
Filed: February 16, 2024, 6:59 PM ET

On February 14, 2024, Ocuphire Pharma, Inc., (the “Company”) announced the appointment of Nirav Jhaveri as the Company’s Chief Financial Officer (“CFO”), effective February 12, 2024

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Nirav Jhaveri was appointed as Chief Financial Officer at Opus Genetics, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On February 14, 2024, Ocuphire Pharma, Inc., (the “Company”) announced the appointment of Nirav Jhaveri as the Company’s Chief Financial Officer (“CFO”), effective February 12, 2024

View on SEC.gov

Opus Genetics, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-24-008352

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.